CNBD1 and gastric cancer: Survival analysis and log-rank tests were performed for CNBD1, showing that it was, indeed, associated with worse outcomes in patients with GC (Supplementary Figure S2G, p = 3.5e−05, HR = 1.62, 95%CI 1.28–2.03, n = 631).